Clinical Trials involving : An update.
作者信息
Moore J E, Millar B C
机构信息
Northern Ireland Public Health Laboratory, Department of Bacteriology, Belfast City Hospital, Belfast, BT9 7AD, Northern Ireland School of Medicine, Dentistry and Biomedical Sciences, The Wellcome-Wolfson Institute for Experimental Medicine, Queen's University, Belfast, BT9 7BL, Northern Ireland School of Biomedical Sciences, Ulster University, Coleraine, BT52 1SA, Northern Ireland Northern Ireland Regional Adult Cystic Fibrosis Centre, Belfast City Hospital, Belfast, BT9 7AB, Northern Ireland.
Northern Ireland Public Health Laboratory, Belfast City Hospital, Lisburn Road, Belfast, BT9 7AD, Northern Ireland, United Kingdom.
出版信息
Ulster Med J. 2025 Apr;94(1):28-30. Epub 2025 Apr 30.
Abstract
摘要
相似文献
1
Clinical Trials involving : An update.涉及临床试验：最新情况。
Ulster Med J. 2025 Apr;94(1):28-30. Epub 2025 Apr 30.
2
Interaction of South Asian spices with conventional antibiotics: Implications for antimicrobial resistance for and cystic fibrosis.南亚香料与传统抗生素的相互作用：对耐药性和囊性纤维化的影响。
Int J Mycobacteriol. 2018 Jul-Sep;7(3):257-260. doi: 10.4103/ijmy.ijmy_72_18.
3
Antimicrobial properties of basidiomycota macrofungi to isolated from patients with cystic fibrosis.从囊性纤维化患者中分离出的担子菌大型真菌的抗菌特性。
Int J Mycobacteriol. 2019 Jan-Mar;8(1):93-97. doi: 10.4103/ijmy.ijmy_167_18.
4
Compassionate Nitric Oxide Adjuvant Treatment of Persistent Mycobacterium Infection in Cystic Fibrosis Patients.同情一氧化氮辅助治疗囊性纤维化患者持续分枝杆菌感染。
Pediatr Infect Dis J. 2018 Apr;37(4):336-338. doi: 10.1097/INF.0000000000001780.
5
Pilot study to test inhaled nitric oxide in cystic fibrosis patients with refractory Mycobacterium abscessus lung infection.一项测试吸入性一氧化氮治疗耐脓肿分枝杆菌肺病的囊性纤维化患者的初步研究。
J Cyst Fibros. 2020 Mar;19(2):225-231. doi: 10.1016/j.jcf.2019.05.002. Epub 2019 May 23.
6
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.囊性纤维化患者非结核分枝杆菌肺部感染的抗生素治疗
Cochrane Database Syst Rev. 2020 Jun 10;6(6):CD010004. doi: 10.1002/14651858.CD010004.pub5.
7
Antimycobacterial activity of nonantibiotics associated with the polypharmacy of cystic fibrosis (CF) against mycobacterium abscessus.与囊性纤维化（CF）多药治疗相关的非抗生素对脓肿分枝杆菌的抗分枝杆菌活性。
Int J Mycobacteriol. 2018 Oct-Dec;7(4):358-360. doi: 10.4103/ijmy.ijmy_142_18.
8
Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options.囊性纤维化个体的感染：治疗选择的综述。
Int J Mol Sci. 2023 Feb 27;24(5):4635. doi: 10.3390/ijms24054635.
9
Improved Clinical Outcome After Treatment of Mycobacterium abscessus Complex Pulmonary Disease in Children With Cystic Fibrosis.囊性纤维化患儿中脓肿分枝杆菌复合群肺病治疗后临床转归的改善。
Pediatr Infect Dis J. 2019 Jul;38(7):660-666. doi: 10.1097/INF.0000000000002274.
10
, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients.铜绿假单胞菌，囊性纤维化患者的新兴且令人担忧的病原体。
Int J Mol Sci. 2019 Nov 22;20(23):5868. doi: 10.3390/ijms20235868.
本文引用的文献
1
Mycobacterium abscessus, a complex of three fast-growing subspecies sharing virulence traits with slow-growing mycobacteria.脓肿分枝杆菌，是由三个快速生长亚种组成的复合体，它们具有与缓慢生长分枝杆菌相似的毒力特征。
Clin Microbiol Infect. 2024 Jun;30(6):726-731. doi: 10.1016/j.cmi.2023.08.036. Epub 2023 Oct 4.
2
The activity of carbapenems alone and in combination with β-lactamase inhibitors against difficult-to-treat mycobacteria; and complex: A systematic review.碳青霉烯类单独及与β-内酰胺酶抑制剂联合应用对难治疗分枝杆菌及复合体的活性：一项系统评价
Int J Mycobacteriol. 2023 Jul-Sep;12(3):211-225. doi: 10.4103/ijmy.ijmy_131_23.
3
New therapeutic strategies for pulmonary diseases - untapping the mycolic acid pathway.肺部疾病的新治疗策略 - 挖掘分枝菌酸途径。
Expert Rev Anti Infect Ther. 2023 Jul-Dec;21(8):813-829. doi: 10.1080/14787210.2023.2224563. Epub 2023 Jun 23.
4
The cell envelope of Mycobacterium abscessus and its role in pathogenesis.脓肿分枝杆菌的细胞包膜及其在发病机制中的作用。
PLoS Pathog. 2023 May 18;19(5):e1011318. doi: 10.1371/journal.ppat.1011318. eCollection 2023 May.
5
Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options.囊性纤维化个体的感染：治疗选择的综述。
Int J Mol Sci. 2023 Feb 27;24(5):4635. doi: 10.3390/ijms24054635.
6
Updated Review on the Mechanisms of Pathogenicity in , a Rapidly Growing Emerging Pathogen.关于一种快速增长的新兴病原体致病性机制的最新综述
Microorganisms. 2022 Dec 29;11(1):90. doi: 10.3390/microorganisms11010090.
7
Why Matter Matters: Fast-Tracking Drug Discovery.为什么物质很重要：加速药物发现。
Molecules. 2022 Oct 17;27(20):6948. doi: 10.3390/molecules27206948.
8
Alternatives to Antibiotics against .对抗……的抗生素替代品
Antibiotics (Basel). 2022 Sep 28;11(10):1322. doi: 10.3390/antibiotics11101322.
9
Virulence-Associated Secretion in .毒力相关分泌在 …… 中。
Front Immunol. 2022 Jul 8;13:938895. doi: 10.3389/fimmu.2022.938895. eCollection 2022.
10
Virulence Mechanisms of : Current Knowledge and Implications for Vaccine Design.《：当前认知及对疫苗设计的意义》的毒力机制
Front Microbiol. 2022 Mar 3;13:842017. doi: 10.3389/fmicb.2022.842017. eCollection 2022.
Zotero 插件